14.65
price down icon6.21%   -0.97
after-market Dopo l'orario di chiusura: 14.67 0.02 +0.14%
loading
Precedente Chiudi:
$15.62
Aprire:
$15.3
Volume 24 ore:
424.93K
Relative Volume:
1.79
Capitalizzazione di mercato:
$1.87B
Reddito:
$7.50M
Utile/perdita netta:
$-81.89M
Rapporto P/E:
0.2763
EPS:
53.0176
Flusso di cassa netto:
$-63.58M
1 W Prestazione:
+31.15%
1M Prestazione:
+40.39%
6M Prestazione:
-18.79%
1 anno Prestazione:
+102.63%
Intervallo 1D:
Value
$14.60
$15.30
Intervallo di 1 settimana:
Value
$10.96
$16.07
Portata 52W:
Value
$5.78
$22.00

Mesoblast Ltd Adr Stock (MESO) Company Profile

Name
Nome
Mesoblast Ltd Adr
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
73
Name
Cinguettio
@Mesoblast
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
MESO's Discussions on Twitter

Confronta MESO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MESO
Mesoblast Ltd Adr
14.65 1.43B 7.50M -81.89M -63.58M 53.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-18 Downgrade Jefferies Buy → Hold
2024-12-23 Downgrade Jefferies Buy → Hold
2024-09-24 Aggiornamento Maxim Group Hold → Buy
2024-08-29 Aggiornamento Jefferies Hold → Buy
2024-07-23 Aggiornamento Piper Sandler Neutral → Overweight
2023-08-31 Aggiornamento Jefferies Hold → Buy
2023-08-07 Downgrade Maxim Group Buy → Hold
2023-08-04 Downgrade Piper Sandler Overweight → Neutral
2023-08-04 Downgrade William Blair Outperform → Mkt Perform
2023-03-09 Iniziato William Blair Outperform
2022-12-06 Downgrade Jefferies Buy → Hold
2022-09-06 Iniziato Piper Sandler Overweight
2021-04-07 Aggiornamento Maxim Group Hold → Buy
2020-12-22 Downgrade Maxim Group Buy → Hold
2020-12-04 Downgrade Chardan Capital Markets Neutral → Sell
2020-10-22 Iniziato RBC Capital Mkts Sector Perform
2020-08-14 Reiterato Maxim Group Buy
2020-05-28 Reiterato H.C. Wainwright Buy
2019-01-31 Ripresa H.C. Wainwright Buy
2018-03-22 Downgrade Credit Suisse Neutral → Underperform
2018-02-28 Reiterato Cantor Fitzgerald Buy
2017-08-31 Iniziato Oppenheimer Outperform
2017-06-08 Iniziato Cantor Fitzgerald Buy
Mostra tutto

Mesoblast Ltd Adr Borsa (MESO) Ultime notizie

pulisher
Jul 18, 2025

Company’s Banking Stock: Dissecting a -4.28% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Novagold Resources Inc (NG) Stock: A Year of Decreases and Increases - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

TV’s 2025 Market Dance: Down -20.11% – Time to Invest? - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Cango Inc ADR (CANG) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Mesoblast Ltd ADR Inc. (MESO) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Innodata Inc (INOD) Stock: A Year of Market Movement, Down and Up - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

BILL Holdings Inc Inc. (BILL) Price Performance: A Fundamental Analysis Perspective - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Burford Capital Limited: Navigating Market Fluctuations with a 3.10B Market Cap - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Chagee Holdings Ltd. ADR (CHA) Stock: A Year of Highs and Lows - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Nano X Imaging Ltd (NNOX) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

LU’s Stock Dilemma: Lufax Holding Ltd ADR’s Market Performance and Outlook - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

ZTO’s Stock Market Adventure: -5.37% YTD Growth Amidst Volatility - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

MGRX’s Market Whiplash: -74.88% YTD Decline, -16.49% Plunge in 30 Days - investchronicle.com

Jul 18, 2025
pulisher
Jul 18, 2025

Mesoblast stock soars after reporting first Ryoncil sales - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Sonim Technologies Inc (SONM) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 18, 2025
pulisher
Jul 17, 2025

Successful Commercial Launch of Ryoncil® - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 14, 2025

An In-Depth Look at Trident Digital Tech Holdings Ltd. ADR Inc. (TDTH) Price Performance During Market Crashes - investchronicle.com

Jul 14, 2025
pulisher
Jul 14, 2025

BTCM: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com

Jul 14, 2025
pulisher
Jul 11, 2025

Perspective Therapeutics Inc (CATX Stock: A Sea of Opportunity - investchronicle.com

Jul 11, 2025
pulisher
Jul 10, 2025

DallasNews Corporation (DALN) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 10, 2025
pulisher
Jul 08, 2025

DraftKings Inc (DKNG) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Jul 08, 2025
pulisher
Jul 07, 2025

TSM’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 07, 2025
pulisher
Jul 01, 2025

GE Vernova Inc (GEV) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com

Jul 01, 2025
pulisher
Jun 20, 2025

Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Jun 20, 2025
pulisher
May 06, 2025

All Markets & Instruments Available to Trade - Capital.com

May 06, 2025
pulisher
Mar 30, 2025

Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil® - thecapitalclub.com.au

Mar 30, 2025
pulisher
Mar 20, 2025

UPDATED: Your guide to February Reporting Season 2020 - Morningstar.com.au

Mar 20, 2025
pulisher
Mar 03, 2025

21 Best-Performing Small-Cap Stocks for March 2025 - NerdWallet

Mar 03, 2025
pulisher
Feb 09, 2025

Why Mesoblast Ltd ADR (NASDAQ: MESO) Is Worth Including On Your Watchlist - Marketing Sentinel

Feb 09, 2025
pulisher
Feb 06, 2025

The 98.76% Simple Moving Average of Mesoblast Ltd ADR’s (MESO) Stock in the Past 200 Days - The News Heater

Feb 06, 2025
pulisher
Feb 01, 2025

Mesoblast Ltd ADR (NASDAQ:MESO) Shares Are Up 10.24 Percent In A Week – But Can The Gains Continue? - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 31, 2025

ASX Lunch Wrap: ASX and gold reset record highs; but Origin cuts its LNG forecast - Stockhead

Jan 31, 2025
pulisher
Jan 10, 2025

Why are Mesoblast shares in a trading halt? - The Motley Fool Australia

Jan 10, 2025
pulisher
Jan 09, 2025

Mesoblast Limited Initiates Trading Halt Pending Financing Announcement - TipRanks

Jan 09, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Jan 02, 2025

Mesoblast (NASDAQ:MESO) Shares Gap UpWhat's Next? - MarketBeat

Jan 02, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 30, 2024

Mesoblast Stock Soars to 52-Week High, Hits $19.15 - Investing.com

Dec 30, 2024
pulisher
Dec 23, 2024

Mesoblast shares downgraded to hold by Jefferies By Investing.com - Investing.com South Africa

Dec 23, 2024
pulisher
Dec 20, 2024

Why the Mesoblast share price is diving 18% after an FDA win - The Motley Fool Australia

Dec 20, 2024
pulisher
Dec 19, 2024

Mesoblast share price rockets 30% on big US FDA news - The Motley Fool Australia

Dec 19, 2024
pulisher
Dec 16, 2024

Mesoblast stock soars to 52-week high, hits $12.21 - Investing.com

Dec 16, 2024
pulisher
Dec 03, 2024

Mesoblast Stock Soars to 52-Week High, Hits $12.19 - Investing.com

Dec 03, 2024
pulisher
Nov 13, 2024

Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com

Nov 13, 2024
pulisher
Oct 08, 2024

JPMorgan Takes Substantial Stake in Mesoblast Ltd - TipRanks

Oct 08, 2024
pulisher
Sep 30, 2024

Mesoblast to raise $50m from top shareholder for product launch - Capital Brief

Sep 30, 2024
pulisher
Jul 22, 2024

Mesoblast: Rolling The Dice On Cellular Medicines (NASDAQ:MESO) - Seeking Alpha

Jul 22, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Apr 10, 2024

Mesoblast Limited: Back From The Dead (NASDAQ:MESO) - Seeking Alpha

Apr 10, 2024
pulisher
Mar 26, 2024

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - TradingView

Mar 26, 2024
pulisher
Mar 24, 2024

11 Best ASX Stocks To Buy Now - Yahoo Finance

Mar 24, 2024

Mesoblast Ltd Adr Azioni (MESO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
Capitalizzazione:     |  Volume (24 ore):